Singular research reports on quantum biopharma ltd.'s strategic advances and pipeline progress

Los angeles, california--(newsfile corp. - june 18, 2025) - singular research, a leading provider of independent research on small-cap companies, today released its analysis of quantum biopharma ltd.'s (nasdaq: qntm) continued progress across its innovative pipeline of treatments for brain disorders and alcohol health.
QNTM Ratings Summary
QNTM Quant Ranking